Cardiopulmonary Bypass Completed Phase 3 Trials for Antithrombin III human (DB11598)

Also known as: Cardiopulmonary bypass / Bypass, Cardiopulmonary

IndicationStatusPhase
DBCOND0032101 (Cardiopulmonary Bypass)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01530737Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac SurgeryTreatment